Showing results (721-730 of 803) with videos related to

Sort By:
Pageof 81
American Heart Journal|July 2, 2005
Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyAnne B Curtis, Bernard J Gersh, Scott D Corley, et al.
American Heart Journal|March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationaleRenato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
Circulation|September 9, 2010
Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countriesAbhinav Goyal, Deepak L Bhatt, P Gabriel Steg, et al.
Circulation|November 13, 2004
Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope managementWin K Shen, Wyatt W Decker, Peter A Smars, et al.
Circulation. Arrhythmia and Electrophysiology|October 26, 2018
Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator ReplacementChance M Witt, Jonathan W Waks, Ramila A Mehta, et al.
Circulation|December 2, 2016
Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 PatientsRowlens M Melduni, Hartzell V Schaff, Hon-Chi Lee, et al.
Journal of Thrombosis and Thrombolysis|July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryLarry R Jackson, Sunghee Kim, Peter Shrader, et al.
Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
Circulation|September 26, 2012
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialMaria Mori Brooks, Bernard R Chaitman, Richard W Nesto, et al.
Pageof 81